Novel Cancer Immunotherapies and Antitumor Immunity
Lead Guest Editor: Lei ZhaoGuest Editors: Jianjun Zhang and Liang Xu
- Novel Cancer Immunotherapies and Antitumor Immunity, Lei Zhao, Jianjun Zhang, Liang Xu, and Hussein A. Abbas
Editorial (2 pages), Article ID 3742061, Volume 2019 (2019) - Cervical Cancer Cells Express Markers Associated with Immunosurveillance, Adriana Gutiérrez-Hoya, Octavio Zerecero-Carreón, Arturo Valle-Mendiola, Martha Moreno-Lafont, Rubén López-Santiago, Benny Weiss-Steider, and Isabel Soto-Cruz
Research Article (10 pages), Article ID 1242979, Volume 2019 (2019) - pDC Activation by TLR7/8 Ligand CL097 Compared to TLR7 Ligand IMQ or TLR9 Ligand CpG, Jing Wu, Shuang Li, Tete Li, Xinping Lv, Mingyou Zhang, Guoxia Zang, Chong Qi, Yong-Jun Liu, Liang Xu, and Jingtao Chen
Research Article (10 pages), Article ID 1749803, Volume 2019 (2019) - Immunoglobulin Gamma-Like Therapeutic Bispecific Antibody Formats for Tumor Therapy, Shixue Chen, Lingling Li, Fan Zhang, Yu Wang, Yi Hu, and Lei Zhao
Review Article (13 pages), Article ID 4516041, Volume 2019 (2019) - Implementation of Mass Cytometry for Immunoprofiling of Patients with Solid Tumors, Ingrid Poláková, Ondřej Pelák, Daniel Thürner, Barbora Pokrývková, Ruth Tachezy, Tomáš Kalina, and Michal Šmahel
Research Article (10 pages), Article ID 6705949, Volume 2019 (2019) - A Novel Anti-EGFR mAb Ame55 with Lower Toxicity and Better Efficacy than Cetuximab When Combined with Irinotecan, Weiyi Qiu, Chang Zhang, Shuang Wang, Xiaoyan Yu, Qiong Wang, Dadi Zeng, Peng Du, Jinling Ma, Yiqiong Zheng, Bo Pang, Yunzhou Yu, Feng Long, Xiaobin Pang, and Zhiwei Sun
Research Article (12 pages), Article ID 3017360, Volume 2019 (2019) - Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens, Ren-You Pan, Wen-Hung Chung, Mu-Tzu Chu, Shu-Jen Chen, Hua-Chien Chen, Lei Zheng, and Shuen-Iu Hung
Review Article (9 pages), Article ID 4325874, Volume 2018 (2018) - The Antitumor Immunity and Tumor Responses of Chemotherapy with or without DC-CIK for Non-Small-Cell Lung Cancer in China: A Meta-Analysis of 28 Randomized Controlled Trials, Zheng Xiao, Cheng-qiong Wang, Ming-hua Zhou, Na-na Li, Yong-ping Sun, Yu-zhi Wang, Shi-yu Liu, Hong-song Yu, Cheng-wen Li, Xian-tao Zeng, Ling Chen, Xin-sheng Yao, and Ji-hong Feng
Research Article (18 pages), Article ID 9081938, Volume 2018 (2018) - HLA-A2-Restricted Epitopes Identified from MTA1 Could Elicit Antigen-Specific Cytotoxic T Lymphocyte Response, Yahong Wu, Wenjie Zhai, Xiuman Zhou, Zhiwei Wang, Yan Lin, Ling Ran, Yuanming Qi, and Yanfeng Gao
Research Article (11 pages), Article ID 2942679, Volume 2018 (2018) - EGFR-Targeted Immunotoxin Exerts Antitumor Effects on Esophageal Cancers by Increasing ROS Accumulation and Inducing Apoptosis via Inhibition of the Nrf2-Keap1 Pathway, Yun Yang, Ziyin Tian, Yanke Ding, Xiaojing Li, Ziheng Zhang, Liu Yang, Fangyu Zhao, Feng Ren, and Rui Guo
Research Article (10 pages), Article ID 1090287, Volume 2018 (2018) - Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models, Qing Zhang, Haixu Zhang, Jiage Ding, Hongyan Liu, Huizhong Li, Hailong Li, Mengmeng Lu, Yangna Miao, Liantao Li, and Junnian Zheng
Research Article (11 pages), Article ID 4263520, Volume 2018 (2018) - Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies, Sandro Matosevic
Review Article (20 pages), Article ID 4054815, Volume 2018 (2018)